z-logo
open-access-imgOpen Access
Serine restriction alters sphingolipid diversity to constrain tumour growth
Author(s) -
Thangaselvam Muthusamy,
Thekla Cordes,
Michal K. Handzlik,
Le You,
Esther W. Lim,
Jivani M. Gengatharan,
Antônio Frederico Michel Pinto,
Mehmet G. Badur,
Matthew J. Kolar,
Martina Wallace,
Alan Saghatelian,
Christian M. Metallo
Publication year - 2020
Publication title -
nature
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 15.993
H-Index - 1226
eISSN - 1476-4687
pISSN - 0028-0836
DOI - 10.1038/s41586-020-2609-x
Subject(s) - serine , alanine , glycine , sphingolipid , biochemistry , biology , ceramide , biosynthesis , amino acid , metabolism , chemistry , enzyme , apoptosis
Serine, glycine and other nonessential amino acids are critical for tumour progression, and strategies to limit their availability are emerging as potential therapies for cancer 1-3 . However, the molecular mechanisms driving this response remain unclear and the effects on lipid metabolism are relatively unexplored. Serine palmitoyltransferase (SPT) catalyses the de novo biosynthesis of sphingolipids but also produces noncanonical 1-deoxysphingolipids when using alanine as a substrate 4,5 . Deoxysphingolipids accumulate in the context of mutations in SPTLC1 or SPTLC2 6,7 -or in conditions of low serine availability 8,9 -to drive neuropathy, and deoxysphinganine has previously been investigated as an anti-cancer agent 10 . Here we exploit amino acid metabolism and the promiscuity of SPT to modulate the endogenous synthesis of toxic deoxysphingolipids and slow tumour progression. Anchorage-independent growth reprogrammes a metabolic network involving serine, alanine and pyruvate that drives the endogenous synthesis and accumulation of deoxysphingolipids. Targeting the mitochondrial pyruvate carrier promotes alanine oxidation to mitigate deoxysphingolipid synthesis and improve spheroid growth, similar to phenotypes observed with the direct inhibition of SPT or ceramide synthesis. Restriction of dietary serine and glycine potently induces the accumulation of deoxysphingolipids while decreasing tumour growth in xenograft models in mice. Pharmacological inhibition of SPT rescues xenograft growth in mice fed diets restricted in serine and glycine, and the reduction of circulating serine by inhibition of phosphoglycerate dehydrogenase (PHGDH) leads to the accumulation of deoxysphingolipids and mitigates tumour growth. The promiscuity of SPT therefore links serine and mitochondrial alanine metabolism to membrane lipid diversity, which further sensitizes tumours to metabolic stress.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here